Clinical Research Canada
With this branch office, Criterium continues to extend its worldwide
clinical trials capabilities to Canada, a long established and steadily
growing area for clinical research studies. Canada's dynamic G8 economy
continues to demonstrate its strong fundamentals and world-leading
capabilities in a range of sectors, including information technology,
engineering, biotech, and aerospace. Canada’s position as a
biotechnology leader—one of the top five countries in the world—is
a reflection of the country’s world-class credentials.
Canada recognizes the economic potential of the biotech industry
and has formally committed itself to become one of the top five countries
in the world for biotech research and development. With an 8% annual
growth rate, Canada is the fourth fastest growing market in the world
for pharmaceuticals. The sector benefits from Canada’s thriving
biotechnology industry, which also fuels pharmaceutical companies’
growth. Add to these advantages a well-educated workforce, highly-trained
scientists and technicians, business-friendly government policies
-- nearly every major pharmaceutical company has manufacturing and/or
R&D operations in Canada.
- Globally-recognized industry
- A vital, proactive approach to R&D
- Facilitated access to export markets
A Snapshot of the Canadian Biotech Sector
- 496 biotechnology companies, public firms making up 17%
- $3.8 billion in biotech revenues, a 96% increase over 1999
- 17,065 products/processes at all stages of development; of these,
nearly 2/3 on the market
- $1.5 billion in R&D spending by industry, an 80% increase
- Public biotechnology firms increased R&D spending by 224%
- Annual federal biotechnology spending $791 million, 96% of it
on R&D (2004-05)
- Human health dominates the Canadian biotechnology scene, accounting
for 53% of firms:
- Biopharmaceutical sales—$2.1 Billion
- Over 78% of all biotechnology-related jobs are in this sector.
(176 bio-pharmaceutical firms—2006)
- Nearly 90% of R&D investments in biotech is dedicated
solely to this sector. (Biopharma R&D—$1.3 Million)
- Toronto has the largest faculty of medicine in North America
and the output of peer-reviewed publications from this area is greater
than any other medical centre in the world.
Research Successes in Canada
- A team from the Faculty of Medicine at Centre Hospitalier universitaire
de Québec at Université Laval recently discovered
a natural defense mechanism in the body deployed to combat nerve
cell degeneration observed in people with Alzheimer’s disease.
The discovery could lead to a new therapeutic approach to Alzheimer’s
- University of Toronto biomedical scientists have pioneered the
genetic mechanisms for several diseases and discovered a way to
increase the yield of stem calls from umbilical cord blood by removing
unwanted cells that inhibit stem cell growth.
- Scientists at McGill University have discovered a gene that controls
the speed at which patients develop tuberculosis. This is a breakthrough
in understanding how a gene can control the time frame between initial
infection and the disease.
- A BC neuroscientist developed the world’s first diagnostic
blood test to detect diseases such as Alzheimer’s, Parkinson’s,
Lou Gehrigs and CJV.
- An international team led by three University of British Columbia
microbiologists has completed the mapping of the genetic makeup
of a soil bacterium (RHA 1), the first organism of its kind to be
completely sequenced. This work illuminates how the soil organism
breaks down PCBs and other toxic wastes, and adapts to the environment
around it. (source: http://investincanada.gc.ca/eng/industry-sectors/biotechnology.aspx)
Criterium Inc conducts National and Multi-National Clinical Trials
in a wide range of Therapeutic Areas. Our personnel have participated
in over 500 studies. Here is a selected list of previous studies:
- Cardiovascular Disease
- Women’s Studies
- Pain Management
- HIV/ Infectious Disease
- Central Nervous System
- Internal Medicine
- Metabolic Disease
All Criterium clients benefit from our efficient technology-based
workflow. Field staff in Canada are supported by centralized Remote
Study Management, Data Management, Statistical Analysis, and Programming
Support services in Criterium’s New York headquarters.
Because of this strong support structure the data are locked sooner,
allowing for statistical analysis, final reports and speedy submission
of studies to the client and agencies. This enables us to set aggressive
timelines, reduce costs and produce very high quality data when completing
the clinical trial process.
Some of the specialized services Criterium provides include:
- Regulatory Services
- Clinical Study Management
- Data Management
- Statistics and Programming
- Pharmacokinetics/Pharmacodynamics – Local Phase I / BE /
- Medical Writing
- Program Management
With experienced personnel including Board Certified Physicians in
each region, Criterium clients benefit from our thorough understanding
of the unique regulatory structures and specialized patient requirements
of each country in which we work.
Clinical Trials Canada
GET TO KNOW US!